71921-105-33 : NDC 2026 Code

71921-105-33 : Tenofovir Disoproxil Fumarate ( Tenofovir Disoproxil Fumarate )

Additionally :

You can get information about “71921-105-33” NDC code in 71921-105-33 in HTML format

HTML | 71921-105-33 in TXT (Plain Text) format

TXT | 71921-105-33 in PDF (Portable Document Format)

PDF | 71921-105-33 in XML format

XML formats.

NDC Code : 71921-105-33 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "71921-105-33",
    "PackageDescription": "30 TABLET, COATED in 1 BOTTLE, PLASTIC (71921-105-33) ",
    "NDC11Code": "71921-0105-33",
    "ProductNDC": "71921-105",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Tenofovir Disoproxil Fumarate",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Tenofovir Disoproxil Fumarate",
    "DosageFormName": "TABLET, COATED",
    "RouteName": "ORAL",
    "StartMarketingDate": "20251126",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA209498",
    "LabelerName": "Florida Pharmaceutical Products, LLC.",
    "SubstanceName": "TENOFOVIR DISOPROXIL FUMARATE",
    "StrengthNumber": "300",
    "StrengthUnit": "mg/1",
    "Pharm_Classes": "Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2025-11-28",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20251126",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}